Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "Official" company response/non-response to 10q questions

Re: pautaotzu... maybe this makes sense now

posted on May 06, 2008 04:09AM

If he does not find a suitable M&A then PTSC can say that they have done extensive DD and have concluded that a buyout of us by TPL at .80 cents is a more than fair offer. The BOD can point to the extrordinary care that they took to ensure this is the correct deceision.



They hired a temp CEO who in turn hired someone else expert in M&A. RG is in there fighting for a reason of why we should not merge with TPL/Alliasense. He is the DUE DILLAGENCE that PTSC must show before the BOD recommends the buyout price. Propabably <1.00 buyout per share.





The acceptance of any such offer before the patent re-examinations and '584 Appeal results are known would be, in my very humble opinion, a total dereliction of fiduciary duty.





Be well

Share
New Message
Please login to post a reply